Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients

doi:10.3748/wjg.v11.i39.6188

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2409)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

408

HTML

1839

Figures (1-1)

162

Sum=2409

Oct 21, 2005 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 21, 2005; 11(39): 6188-6192
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6188

Open in New Tab Full Size Figure Download Figure

Figure 1 Outcome of 12 HCV-infected patients with genotype 2 or 3 after the end of treatment and follow-up. Abbreviations: EOT (end of treatment), IFN (interferon alpha).

Citation: Wietzke-Braun P, Meier V, Neubauer-Saile K, Mihm S, Ramadori G. Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients. World J Gastroenterol 2005; 11(39): 6188-6192
URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6188.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6188